Receptor News and Research

RSS
Study: Targeting specific genomic mutation in breast cancer improves survival

Study: Targeting specific genomic mutation in breast cancer improves survival

Researchers discover new structure in human cells

Researchers discover new structure in human cells

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress

ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

Breast cancer survival could be extended with two new drug combinations

Breast cancer survival could be extended with two new drug combinations

Research provides insight into neurobiology of aggression and bullying

Research provides insight into neurobiology of aggression and bullying

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women

New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women

High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients

High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients